AKT1 and neoplasm: Serial dilutions of BEAS-C and BEAS-Akt1-E17K cells grown as LCSs (4 × 103, 4 × 104) were injected subcutaneously into NOD/SCID mice and monitored for tumor appearance up to ~7 months.